在两个历史队列中,引入口服降糖药治疗妊娠糖尿病后的孕产妇和新生儿结局与胰岛素单药治疗相当。

IF 1.2
V Nicolaou, L Soepnel, K R Huddle, N Levitt, K Klipstein-Grobusch, S A Norris
{"title":"在两个历史队列中,引入口服降糖药治疗妊娠糖尿病后的孕产妇和新生儿结局与胰岛素单药治疗相当。","authors":"V Nicolaou,&nbsp;L Soepnel,&nbsp;K R Huddle,&nbsp;N Levitt,&nbsp;K Klipstein-Grobusch,&nbsp;S A Norris","doi":"10.7196/SAMJ.2020.v110i2.14024","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Gestational diabetes mellitus (GDM), a disorder of glucose intolerance first encountered during pregnancy, has far-reaching implications for both mother and child. Insulin therapy remains the 'gold standard' of care, with oral hypoglycaemic agents (OHAs) increasingly being viewed as potential alternatives.</p><p><strong>Objectives: </strong>To compare maternal and neonatal outcomes in two cohorts of women with GDM exposed to either insulin monotherapy or OHAs.</p><p><strong>Methods: </strong>A retrospective medical record review at Chris Hani Baragwanath Academic Hospital in South Africa was conducted for women with GDM diagnosed using the 100 g oral glucose tolerance test and/or random capillary blood glucose &gt;11.1 mmol/L in 2010 - 2014. The findings were compared with a previous audit at the same clinic for the period 1992 - 2002. Variables of interest included maternal demographics, maternal comorbidities, glycaemic indices, treatments used during pregnancy, and obstetric and neonatal outcomes.</p><p><strong>Results: </strong>A total of 192 women with GDM were identified for 2010 - 2014, and there were 348 women in the previous audit (1992 - 2002). Baseline characteristics and outcomes of women in the two cohorts were similar apart from earlier presentation (mean (standard deviation) gestational age (GA) 27 (7.5) weeks v. 28.3 (6.4) weeks; p=0.04), lower GA at delivery (36.3 (3.6) weeks v. 37 (1.6) weeks); p=0.008) and lower macrosomia rates (12.5% v. 4.9%; p=0.011) in the later cohort. When comparing the individual OHAs against insulin in the later cohort, both agents were comparable to insulin in terms of maternal and neonatal outcomes.</p><p><strong>Conclusions: </strong>This study contributes to the paucity of data on the safety of OHAs in GDM pregnancy in terms of maternal and neonatal outcomes. OHAs were shown to be an effective alternative to insulin for women with GDM in whom lifestyle measures fail, particularly in a resource-poor setting.</p>","PeriodicalId":520778,"journal":{"name":"South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde","volume":" ","pages":"154-158"},"PeriodicalIF":1.2000,"publicationDate":"2020-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.7196/SAMJ.2020.v110i2.14024","citationCount":"3","resultStr":"{\"title\":\"Maternal and neonatal outcomes following the introduction of oral hypoglycaemic agents for gestational diabetes mellitus were comparable to insulin monotherapy in two historical cohorts.\",\"authors\":\"V Nicolaou,&nbsp;L Soepnel,&nbsp;K R Huddle,&nbsp;N Levitt,&nbsp;K Klipstein-Grobusch,&nbsp;S A Norris\",\"doi\":\"10.7196/SAMJ.2020.v110i2.14024\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Gestational diabetes mellitus (GDM), a disorder of glucose intolerance first encountered during pregnancy, has far-reaching implications for both mother and child. Insulin therapy remains the 'gold standard' of care, with oral hypoglycaemic agents (OHAs) increasingly being viewed as potential alternatives.</p><p><strong>Objectives: </strong>To compare maternal and neonatal outcomes in two cohorts of women with GDM exposed to either insulin monotherapy or OHAs.</p><p><strong>Methods: </strong>A retrospective medical record review at Chris Hani Baragwanath Academic Hospital in South Africa was conducted for women with GDM diagnosed using the 100 g oral glucose tolerance test and/or random capillary blood glucose &gt;11.1 mmol/L in 2010 - 2014. The findings were compared with a previous audit at the same clinic for the period 1992 - 2002. Variables of interest included maternal demographics, maternal comorbidities, glycaemic indices, treatments used during pregnancy, and obstetric and neonatal outcomes.</p><p><strong>Results: </strong>A total of 192 women with GDM were identified for 2010 - 2014, and there were 348 women in the previous audit (1992 - 2002). Baseline characteristics and outcomes of women in the two cohorts were similar apart from earlier presentation (mean (standard deviation) gestational age (GA) 27 (7.5) weeks v. 28.3 (6.4) weeks; p=0.04), lower GA at delivery (36.3 (3.6) weeks v. 37 (1.6) weeks); p=0.008) and lower macrosomia rates (12.5% v. 4.9%; p=0.011) in the later cohort. When comparing the individual OHAs against insulin in the later cohort, both agents were comparable to insulin in terms of maternal and neonatal outcomes.</p><p><strong>Conclusions: </strong>This study contributes to the paucity of data on the safety of OHAs in GDM pregnancy in terms of maternal and neonatal outcomes. OHAs were shown to be an effective alternative to insulin for women with GDM in whom lifestyle measures fail, particularly in a resource-poor setting.</p>\",\"PeriodicalId\":520778,\"journal\":{\"name\":\"South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde\",\"volume\":\" \",\"pages\":\"154-158\"},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2020-01-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.7196/SAMJ.2020.v110i2.14024\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.7196/SAMJ.2020.v110i2.14024\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7196/SAMJ.2020.v110i2.14024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 3

摘要

背景:妊娠期糖尿病(GDM)是一种首次在妊娠期间出现的葡萄糖耐受不良的疾病,对母亲和孩子都有深远的影响。胰岛素治疗仍然是治疗的“金标准”,口服降糖药(OHAs)越来越被视为潜在的替代方案。目的:比较两组接受胰岛素单药治疗或oha治疗的GDM妇女的孕产妇和新生儿结局。方法:回顾性分析2010 - 2014年在南非Chris Hani Baragwanath学术医院进行100g口服葡萄糖耐量试验和/或随机毛细血管血糖≤11.1 mmol/L诊断为GDM的妇女的病历。调查结果与1992年至2002年期间同一诊所的前一次审计进行了比较。感兴趣的变量包括产妇人口统计、产妇合并症、血糖指数、妊娠期间使用的治疗方法以及产科和新生儿结局。结果:2010 - 2014年共发现了192名患有GDM的女性,而在上一次审计(1992 - 2002年)中有348名女性。两个队列中妇女的基线特征和结果相似,除了更早出现(平均(标准差)胎龄(GA) 27(7.5)周vs 28.3(6.4)周;p=0.04),分娩时GA较低(36.3(3.6)周vs 37(1.6)周);P =0.008)和更低的巨大儿发生率(12.5% vs . 4.9%;P =0.011)。当在后期队列中比较个体oha与胰岛素时,两种药物在孕产妇和新生儿结局方面与胰岛素相当。结论:从孕产妇和新生儿结局的角度来看,本研究有助于缺乏关于妊娠糖尿病妊娠中oha安全性的数据。对于生活方式措施失败的GDM妇女,特别是在资源贫乏的环境中,oha被证明是胰岛素的有效替代。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Maternal and neonatal outcomes following the introduction of oral hypoglycaemic agents for gestational diabetes mellitus were comparable to insulin monotherapy in two historical cohorts.

Background: Gestational diabetes mellitus (GDM), a disorder of glucose intolerance first encountered during pregnancy, has far-reaching implications for both mother and child. Insulin therapy remains the 'gold standard' of care, with oral hypoglycaemic agents (OHAs) increasingly being viewed as potential alternatives.

Objectives: To compare maternal and neonatal outcomes in two cohorts of women with GDM exposed to either insulin monotherapy or OHAs.

Methods: A retrospective medical record review at Chris Hani Baragwanath Academic Hospital in South Africa was conducted for women with GDM diagnosed using the 100 g oral glucose tolerance test and/or random capillary blood glucose >11.1 mmol/L in 2010 - 2014. The findings were compared with a previous audit at the same clinic for the period 1992 - 2002. Variables of interest included maternal demographics, maternal comorbidities, glycaemic indices, treatments used during pregnancy, and obstetric and neonatal outcomes.

Results: A total of 192 women with GDM were identified for 2010 - 2014, and there were 348 women in the previous audit (1992 - 2002). Baseline characteristics and outcomes of women in the two cohorts were similar apart from earlier presentation (mean (standard deviation) gestational age (GA) 27 (7.5) weeks v. 28.3 (6.4) weeks; p=0.04), lower GA at delivery (36.3 (3.6) weeks v. 37 (1.6) weeks); p=0.008) and lower macrosomia rates (12.5% v. 4.9%; p=0.011) in the later cohort. When comparing the individual OHAs against insulin in the later cohort, both agents were comparable to insulin in terms of maternal and neonatal outcomes.

Conclusions: This study contributes to the paucity of data on the safety of OHAs in GDM pregnancy in terms of maternal and neonatal outcomes. OHAs were shown to be an effective alternative to insulin for women with GDM in whom lifestyle measures fail, particularly in a resource-poor setting.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信